Stage 4 Chronic Kidney Disease
Also known as: CKD Stage 4 / Chronic Kidney Disease Stage 4 / Chronic kidney disease / Chronic Kidney Diseases / Chronic kidney disease (CKD)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00146 | Calcifediol | The major circulating metabolite of vitamin D3 (cholecalciferol). It is produced in the liver and is the best indicator of the body's vitamin D stores. It is effective in the treatment of rickets and osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. |
| DB06410 | Doxercalciferol | Doxercalciferol is a synthetic vitamin D2 analog that undergoes metabolic activation in vivo to form 1α,25-dihydroxyvitamin D2 (1α,25-(OH)2D2), a naturally occurring, biologically active form of vitamin D2. Doxercalciferol is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 chronic kidney disease. Doxercalciferol is marketed under the brand name Hectoral by Genzyme Corporation, and is manufactured by Catalent Pharma Solutions, Inc. |
| DB00910 | Paricalcitol | Paricalcitol is a synthetic vitamin D analog. Paricalcitol has been used to reduce parathyroid hormone levels. Paricalcitol is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00945 | Acetylsalicylic acid | 3 | Unknown Status | 1 |
| DB00658 | Sevelamer | 3 | Not Yet Recruiting | 1 |
| DB00146 | Calcifediol | 4 | Recruiting | 1 |
| DB00169 | Cholecalciferol | 4 | Recruiting | 1 |
| DB00910 | Paricalcitol | 4 | Recruiting | 1 |